Market Closed -
Other stock markets
|
Pre-market 08:06:22 am | |||
850 USD | +1.52% | 853.4 | +0.40% |
01:00pm | US FDA advisers to review Eli Lilly Alzheimer's drug | RE |
12:55pm | Eli Lilly Study Shows Tirzepatide Superior to Placebo | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.83% | 248B | |
-1.72% | 219B | |
+11.24% | 216B | |
+5.90% | 164B | |
-0.73% | 162B | |
+0.31% | 123B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Transcript : Eli Lilly and Company, Q2 2023 Earnings Call, Aug 08, 2023